KMT2A and acute myeloid leukemia: Another comprehensive overview of miRNA expression showed that samples with core-binding factor AML and promyelocytic leukemia differed from each other and could be distinguished from MLL-rearranged AML subtypes by differentially expressed miRNAs that included miR-126, -146a, -181a/b, -100, and miR-125b [78].